loader
Please Wait
Applying Filters...

Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    List of Drug Master Files (DMF) for 15262 Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Amphastar Pharmaceuticals

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 Amphastar Pharmaceuticals (1)

    filter

    01 RECOMBINANT HUMAN INSULIN (1)

    filter

    01 U.S.A (1)

    filter

    01 Active (1)

    filter

    01 Blank (1)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us

    AMPHASTAR FRANCE PHARMACEUTICALS SA...

    Contact Supplier
    • FDA
    • EDQM
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    RECOMBINANT HUMAN INSULIN

    PDF Supplier PDF
    URL Supplier Web Content
    15262
    Active
    2001-02-05
    N/A
    II
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for Drug Master Files (DMF) for 15262 of Amphastar France Pharmaceuticals Sas

    Looking for Drug Master Files (DMF) for 15262 of Amphastar France Pharmaceuticals Sas 1

    20

    Amphastar France Pharmaceuticals Sas, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

    One of their notable products is RECOMBINANT HUMAN INSULIN, with a corresponding US DMF Number 15262.

    Remarkably, this DMF maintains an Active status since its submission on February 05, 2001, highlighting commitment to regulatory compliance.

    Post Enquiry
    POST ENQUIRY